BTMD Stock Overview
biote Corp. operates in medical practice-building business within the hormone optimization space.
+ 1 more risk
biote Corp. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$4.06|
|52 Week High||US$10.53|
|52 Week Low||US$2.00|
|1 Month Change||-7.94%|
|3 Month Change||-7.73%|
|1 Year Change||-58.27%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-59.60%|
Recent News & Updates
biote initiated as a buy at Truist on leadership in hormone optimization; sees 138% upsideSep 27
Biote partners with IMAC HoldingsSep 07
|BTMD||US Pharmaceuticals||US Market|
Return vs Industry: BTMD underperformed the US Pharmaceuticals industry which returned 12.2% over the past year.
Return vs Market: BTMD underperformed the US Market which returned -20.5% over the past year.
|BTMD Average Weekly Movement||6.0%|
|Pharmaceuticals Industry Average Movement||11.0%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: BTMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: BTMD's weekly volatility has decreased from 12% to 6% over the past year.
About the Company
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient’s hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women.
biote Corp. Fundamentals Summary
|BTMD fundamental statistics|
Is BTMD overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BTMD income statement (TTM)|
|Cost of Revenue||US$52.68m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||1.89|
|Net Profit Margin||68.16%|
How did BTMD perform over the long term?See historical performance and comparison